Iovance Biotherapeutics, Inc. (IOVA) stock analysis

IOVA · Iovance Biotherapeutics, Inc.

Latest recorded price: USD 7.55

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: free cash flow margin -127.6%, ROIC -98.6%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare